Despite the stated limitations, we consider that the decrease in the CD4+ T type of lymphocytes in peripheral blood with the increasing PSA level and pathological stage may become a prognostic marker of PCa and play a role in the treatment decision to be taken afterward. The gene discussed is KLK3; the disease is posterior cortical atrophy.